Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted as a cocktail-study namely an open-label, randomized, two-sequence,
two-period crossover, cocktail study where a combination of cocktail-drugs is used to
illustrate whether or not, or to what degree dicloxacillin affects the level of activity of
the 5 most important CYP enzymes and therefore plays a potentially decisive role in serious
drug-drug interactions.